|
?:authorAffiliation
|
-
[\'Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.\', \'Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.\', \'Harvard Medical School, Boston, MA, USA.\', \'University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.\', \'Adaptive Biotechnologies, Seattle, WA, USA.\', \'Icahn School of Medicine at Mount Sinai, New York, NY, USA.\', \'Janssen Vaccines & Prevention, Leiden, The Netherlands.\', \'Janssen Research & Development, Beerse, Belgium.\', \'Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA. dbarouch@bidmc.harvard.edu.\', \'Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA. dbarouch@bidmc.harvard.edu.\', \'Harvard Medical School, Boston, MA, USA. dbarouch@bidmc.harvard.edu.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}